MLP Second Quarter 2025 Earnings: Misses Expectations

MLP (ETR:MLP) Second Quarter 2025 Results

Key Financial Results

• Revenue: €228.4m (flat on 2Q 2024).
• Net income: €1.29m (down 88% from 2Q 2024).
• Profit margin: 0.6% (down from 4.5% in 2Q 2024).
• EPS: €0.012 (down from €0.09 in 2Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

MLP Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 7.8%. Earnings per share (EPS) also missed analyst estimates by 89%.

Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Capital Markets industry in Germany.

Performance of the German Capital Markets industry.

The company's shares are down 9.9% from a week ago.

Valuation

Following the latest earnings results, MLP may be undervalued based on 6 different valuation benchmarks we assess. Discover what analysts are forecasting and how the current share price shapes up by clicking here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.